PRINTA statement issued on February 14th, by the FDA, warns patients and health professionals that a counterfeit version of Avastin 400 mg may have filtered down to some medical practices in the United States. The counterfeit version does not contain...
News Aggregator
Our news aggregator keeps you informed of the latest stories on macular disease. Whether browsing current news or hunting for a particular article, you have several options for your search. You can look in a specific category (e.g., “current therapies”) or within a time frame (“last week”) or you can use the search engine to find key words (“Jane Brody”). You can subscribe to receive email bulletins customized to your interests on current news and developments.
News Categories
GET AUTOMATIC UPDATES
Only the News You Want
Subscribe to Macula.Org news by category, topic or even the name of a disease!
CLICK HERE TO LEARN HOW.
Guided Search
Cross Linking
When one term is used to define another term, you can click between the two, so that everything in the definition is clearly explained.
Search Capabilities
Enter a word or phrase in the box below. You will be given all the news articles that contain that word or phrase.
Keyword search
Share this page
Latest News
Post date: Tuesday, December 27, 2011 - 12:56
Eylea (VEGF Trap-eye) has been approved by the FDA. The drug achieves the same results as Lucentis but after a monthly injection for three months it is then injected every two months. Pricewise it is similar to Lucentis. The...
Post date: Tuesday, December 27, 2011 - 12:50
A study report from the nutrition research center at Tufts University reveals a delay in development of AMD-like lesions as the result of a lower glycemic index (GI) diet. The mice on the lower GI diet had less accumulations of debris in...
Featured News
Post date: Wednesday, February 22, 2012 - 09:43
A statement issued on February 14th, by the FDA, warns patients and health professionals that a counterfeit version of Avastin 400 mg may have filtered down to some medical practices in the United States. The counterfeit version does not contain the...
Post date: Tuesday, December 27, 2011 - 12:56
Eylea (VEGF Trap-eye) has been approved by the FDA. The drug achieves the same results as Lucentis but after a monthly injection for three months it is then injected every two months. Pricewise it is similar to Lucentis. The...
Post date: Tuesday, December 27, 2011 - 12:50
A study report from the nutrition research center at Tufts University reveals a delay in development of AMD-like lesions as the result of a lower glycemic index (GI) diet. The mice on the lower GI diet had less accumulations of debris in the...
